FCF strives to be in the forefront of research on fibrolamellar carcinoma (FLC). Our Medical & Scientific Advisory Board is comprised of distinguished physicians, scientists, and researchers who have agreed to advise the Foundation based on their extensive clinical and/or scientific experience. Together, they represent institutions and laboratories at the forefront of both fibrolamellar research and patient care.
A brief biography of each MSAB member can be found by clicking on their name or photograph.
These advisors, working closely with FCF’s Chief Science Officer (Mark Furth, PhD) and FCF’s Research Program Director (Payal Ray, PhD), provide strategic direction for our research programs and play a key role in guiding and prioritizing FCF’s research investments.
Medical & Scientific Advisory Board (MSAB)
| Name | Position |
|---|---|
| Ghassan Abou-Alfa, MD | Medical Oncologist Gastrointestinal Oncology Memorial Sloan Kettering Cancer Center New York, NY |
| Mitesh Borad, MD | Professor of Medicine Mayo Clinic College of Medicine and Science Phoenix, AZ |
| David Drewry, PhD | Professor, Principal Scientist Structural Genomics Consortium, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill, NC |
| John Gordan, MD, PhD | Assistant Professor Hematology and Oncology University of California, San Francisco (UCSF) San Francisco, CA |
| William Harris, MD | Associate Professor Division of Hematology and Oncology, Department of Medicine, University of Washington Clinical Research Division, Fred Hutchinson Cancer Center Seattle, WA |
| Elizabeth M. Jaffee, MD | Deputy Director, Sidney Kimmel Comprehensive Cancer Center Professor of Oncology, Bloomberg-Kimmel Institute for Immunotherapy Johns Hopkins University Baltimore, MD |
| Razelle Kurzrock, MD | Professor of Medicine Associate Director of Clinical Research, Medical College of Wisconsin Cancer Center Center Associate Director, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine Founding Director, Michels Rare Cancers Research Laboratories Medical College of Wisconsin Milwaukee, WI |
| Allison F. O’Neill, MD | Director, Pediatric Liver Tumor Program Dana-Farber Cancer Institute Boston Children’s Hospital Harvard Medical School Boston, MA |
| Corrie Painter, PhD | Venture Partner Even One Ventures Boston, MA |
| John D. Scott, PhD | Edwin G. Krebs – Speights Professor of Cell Signaling and Cancer Biology Chairman, Department of Pharmacology University of Washington School of Medicine Seattle, WA |
| Mark Yarchoan, MD | Associate Professor of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University Baltimore, MD |
| Jessica Zucman-Rossi, MD, PhD | Professor of Oncology Director, INSERM Unit “Functional Genomics of Solid Tumors” Université Paris Descartes Paris, France |
MSAB Members Emeritus
| Name | Position |
|---|---|
| John Craig, MD, PhD | Medical Director (retired) St. Jude Medical Center Fullerton, CA Member, Board of Directors Fibrolamellar Cancer Foundation |
| Lola Reid, PhD | Professor Department of Cell Biology and Physiology University of North Carolina Chapel Hill, NC |